Cargando…
Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
Genome-editing technologies that enable the introduction of precise changes in DNA sequences have the potential to lead to a new class of treatments for genetic diseases. Epidermolysis bullosa (EB) is a group of rare genetic disorders characterized by extreme skin fragility. The recessive dystrophic...
Autores principales: | Bonafont, Jose, Mencía, Angeles, Chacón-Solano, Esteban, Srifa, Wai, Vaidyanathan, Sriram, Romano, Rosa, Garcia, Marta, Hervás-Salcedo, Rosario, Ugalde, Laura, Duarte, Blanca, Porteus, Matthew H., Del Rio, Marcela, Larcher, Fernando, Murillas, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178438/ https://www.ncbi.nlm.nih.gov/pubmed/33609734 http://dx.doi.org/10.1016/j.ymthe.2021.02.019 |
Ejemplares similares
-
Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing
por: Bonafont, Jose, et al.
Publicado: (2019) -
Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
por: Chamorro, Cristina, et al.
Publicado: (2016) -
Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
por: García, Marta, et al.
Publicado: (2022) -
An RNA-targeted therapy for dystrophic epidermolysis bullosa
por: Peking, Patricia, et al.
Publicado: (2017) -
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
por: Hainzl, Stefan, et al.
Publicado: (2017)